Skip to content
In English |
En español
Search
DMIST, the Digital Mammographic Imaging Screening Trial, is a research study sponsored by the U.S. National Cancer Institute to compare digital mammography to conventional screen-film mammography.
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
DMIST Updates
Information from the NCI Press Office
Digital Mammography Trial Results Announced: Women with Dense Breasts, Women Younger than 50, and Those Who are Perimenopausal May Benefit from Digital Mammograms
(Posted: 09/16/2005) - A new study from the NCI shows that currently available screening methods such as transvaginal ultrasound and testing for a protein biomarker called CA-125, alone or in combination, can detect ovarian cancer but can also produce many false-positive test results, causing needless surgery.
Questions and Answers
;
"Fast Facts": The DMIST Study Results
Digital vs. Film Mammography in the Digital Mammographic Imaging Screening Trial (DMIST): Questions and Answers
(Posted: 09/16/2005) - DMIST showed that, for the entire population of women studied, digital and film mammography had very similar screening accuracy.
"Fast Facts": The DMIST Study Results
(Posted: 09/16/2005) - The Digital Mammographic Screening Trial (DMIST) showed that, for the entire population of women studied, digital and film mammography had very similar screening accuracy.
NCI Home
|
Text-Only Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute